Bronchoscopic microsampling to analyze the epithelial lining fluid of patients with pulmonary Mycobacterium avium complex disease

Respiration

Volumn 76, Issue 3, 2008, Pages 338-343

  Nishimura, Tomoyasu ^a   Hasegawa, Naoki ^a   Watanabe, Masazumi ^a   Takebayashi, Toru ^a   Tasaka, Sadatomo ^a   Ishizaka, Akitoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bronchoscopic microsampling; Epithelial lining fluid; Interferon ; KL 6; Mycobacterium avium; Pulmonary Mycobacterium avium complex disease

Indexed keywords

BIOCHEMICAL MARKER; BIOLOGICAL MARKER; GAMMA INTERFERON; KL 6 PROTEIN; MUCIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; BRONCHOSCOPIC MICROSAMPLING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EPITHELIAL LINING FLUID; FEMALE; HUMAN; INFLAMMATION; INTRACELLULAR FLUID; LUNG DISEASE; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SAMPLING; SPUTUM CULTURE; SYMPTOM;

ADULT; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CASE-CONTROL STUDIES; EPITHELIUM; FEMALE; HUMANS; INTERFERON-GAMMA; LUNG; MALE; MIDDLE AGED; MUCIN-1; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 53149147793     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000148063     Document Type: Article

References (30)

1. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 1997;156:S1-S25.
2. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K: An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.
3. Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, Figueroa WG, Fish JE: Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989;321:863-868.
4. Yamazaki Y, Kubo K, Sekiguchi M, Honda T: Analysis of BAL fluid in M. avium-intracellulare infection in individuals without predisposing lung disease. Eur Respir J 1998;11:1227-1231.
5. Reynolds HY: Bronchoalveolar lavage. Am Rev Respir Dis 1987;135:250-263.
6. Clinical guidelines and indications for bronchoalveolar lavage (BAL): report of the European Society of Pneumology Task Group on BAL. Eur Respir J 1990;3:937-976.
7. Strumpf IJ, Feld MK, Cornelius MJ, Keogh BA, Crystal RG: Safety of fiberoptic bronchoalveolar lavage in evaluation of interstitial lung disease. Chest 1981;80:268-271.
8. Burns DM, Shure D, Francoz R, Kalafer M, Harrell J, Witztum K, Moser KM: The physiologic consequences of saline lobar lavage in healthy human adults. Am Rev Respir Dis 1983;127:695-701.
9. Ishizaka A, Watanabe M, Yamashita T, Ogawa Y, Koh H, Hasegawa N, Nakamura H, Asano K, Yamaguchi K, Kotani M, Kotani T, Morisaki H, Takeda J, Kobayashi K, Ogawa S: New bronchoscopic microsample probe to measure the biochemical constituents in epithelial lining fluid of patients with acute respiratory distress syndrome. Crit Care Med 2001;29:896-898.
10. Ishizaka A, Matsuda T, Albertine KH, Koh H, Tasaka S, Hasegawa N, Kohno N, Kotani T, Morisaki H, Takeda J, Nakamura M, Fang X, Martin TR, Matthay MA, Hashimoto S: Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2004;286:L1088-L1094.
11. Watanabe M, Ishizaka A, Ikeda E, Ohashi A, Kobayashi K: Contributions of bronchoscopic microsampling in the supplemental diagnosis of small peripheral lung carcinoma. Ann Thorac Surg 2003;76:1668-1672, discussion 1673.
12. Yamazaki K, Ogura S, Ishizaka A, Oh-hara T, Nishimura M: Bronchoscopic microsampling method for measuring drug concentration in epithelial lining fluid. Am J Respir Crit Care Med 2003;168:1304-1307.
13. Greene C, Taggart C, Lowe G, Gallagher P, McElvaney N, O'Neill S: Local impairment of anti-neutrophil elastase capacity in community-acquired pneumonia. J Infect Dis 2003;188:769-776.
14. Myojo M, Fujiuchi S, Matsumoto H, Yamazaki Y, Takahashi M, Satoh K, Takeda A, Nishigaki Y, Okamoto K, Fujita Y, Fujikane T, Shimizu T: Disseminated Mycobacterium avium complex (DMAC) in an immunocompetent adult. Int J Tuberc Lung Dis 2003;7:498-501.
15. Dorman SE, Holland SM: Mutation in the signal-transducing chain of the interferongamma receptor and susceptibility to mycobacterial infection. J Clin Invest 1998;101:2364-2369.
16. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M: A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996;335:1941-1949.
17. Garcia VE, Uyemura K, Sieling PA, Ochoa MT, Morita CT, Okamura H, Kurimoto M, Rea TH, Modlin RL: IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. J Immunol 1999;162:6114-6121.
18. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M: New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 1989;96:68-73.
19. Hirasawa Y, Kohno N, Yokoyama A, Inoue Y, Abe M, Hiwada K: KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol 1997;17:501-507.
20. Matsuyama W, Hashiguchi T, Matsumuro K, Iwami F, Hirotsu Y, Kawabata M, Arimura K, Osame M: Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis. Am J Respir Crit Care Med 2000;162:1120-1122.
21. Alatas F, Alatas O, Metintas M, Ozarslan A, Erginel S, Yildirim H: Vascular endothelial growth factor levels in active pulmonary tuberculosis. Chest 2004;125:2156-2159.
22. Nishigaki Y, Fujiuchi S, Fujita Y, Yamazaki Y, Sato M, Yamamoto Y, Takeda A, Fujikane T, Shimizu T, Kikuchi K: Increased serum level of vascular endothelial growth factor in Mycobacterium avium complex infection. Respirology 2006;11:407-413.
23. Mittrucker HW, Steinhoff U, Kohler A, Krause M, Lazar D, Mex P, Miekley D, Kaufmann SH: Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proc Natl Acad Sci USA 2007;104:12434-12439.
24. Shiratsuchi H, Ellner JJ: Expression of IL-18 by Mycobacterium avium-infected human monocytes; association with M. avium virulence. Clin Exp Immunol 2001;123:203-209.
25. Dinarello CA, Fantuzzi G: Interleukin-18 and host defense against infection. J Infect Dis 2003;187(suppl 2):S370-S384.
26. Vankayalapati R, Wizel B, Samten B, Griffith DE, Shams H, Galland MR, Von Reyn CF, Girard WM, Wallace RJ Jr, Barnes PF: Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex. J Infect Dis 2001;183:478-484.
27. Inoue Y, Nishimura K, Shiode M, Akutsu H, Hamada H, Fujioka S, Fujino S, Yokoyama A, Kohno N, Hiwada K: Evaluation of serum KL-6 levels in patients with pulmonary tuberculosis. Tuber Lung Dis 1995;76:230-233.
28. Fujita J, Ohtsuki Y, Suemitsu I, Shigeto E, Yamadori I, Obayashi Y, Miyawaki H, Dobashi N, Matsushima T, Takahara J: Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracellulare complex disease. Eur Respir J 1999;13:535-540.
29. Fujita J, Ohtsuki Y, Shigeto E, Suemitsu I, Yamadori I, Bandoh S, Shiode M, Nishimura K, Hirayama T, Matsushima T, Fukunaga H, Ishida T: Pathological findings of bronchiectases caused by Mycobacterium avium intracellulare complex. Respir Med 2003;97:933-938.
30. Sasabayashi M, Yamazaki Y, Tsushima K, Hatayama O, Okabe T: Usefulness of bronchoscopic microsampling to detect the pathogenic bacteria of respiratory infection. Chest 2007;131:474-479.